<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01327248</url>
  </required_header>
  <id_info>
    <org_study_id>FRA-BO</org_study_id>
    <nct_id>NCT01327248</nct_id>
  </id_info>
  <brief_title>Clinical Status and Bronchial Inflammation in Patients With Bronchiolitis Obliterans</brief_title>
  <acronym>Frabo</acronym>
  <official_title>Clinical Status and Bronchial Inflammation in Patients With Bronchiolitis Obliterans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this case-control study is the characterization of the bronchial and systemic
      inflammation of children and young adults with bronchiolitis obliterans.

      On the first visit subjects are asked to perform a lung function test (spirometry, body
      plethysmography with helium). Further levels of eNO and eCO are determined. A blood sample is
      drawn to describe the inflammatory status. Bronchial inflammation will be measured in induced
      sputum. At the second visit, a non-specific bronchial provocation testing (PD20 FEV1
      methacholine) is performed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives:

      The aim of this study is the characterization of patients with bronchiolitis obliterans in
      terms of lung function, bronchial hyperreactivity and the degree of the systemic and
      bronchial inflammation.

      Sputum and serum samples are analyzed by quantitative real-time polymerase chain reaction
      (PCR) (qRT-PCR) and by cytometric bead assay (CBA). Components of the innate immune system
      (mannose-binding protein, TLR recognition proteins and surfactant proteins) are genetically
      determined from sputum or blood respectively. In the conduct of this study the investigators
      will retrospectively and systematically evaluate the available high-resolution computed
      tomography (HRCT) studies of affected patients

      Methods and Work Programme:

      This study consists of two study visits (V1 and V2)

      V1:

        -  Measurement of nitric oxide in expired air (eNO)

        -  Measurement of carbon monoxide in the exhaled air (eCO)

        -  Lung function testing with spirometry and body plethysmography

        -  Blood test: blood count, CRP, RAST, serum inflammatory mediators, genetic markers of the
           non-specific pulmonary defense system

        -  Induced sputum for inflammatory mediators and microbiological investigations

      V2:

      â€¢ Unspecific bronchial provocation test with methacholine (PD20 FEV1 methacholine)

      Study population:

      Children and young people (6 - 25 years of age). Both the patients and the healthy subjects
      are recruited from the outpatient clinic of Pediatric Allergy and Pulmonology.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>Bronchiolitis Obliterans</condition>
  <arm_group>
    <arm_group_label>affected patients</arm_group_label>
    <description>20 Patients suffering from bronchiolitis obliterans</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-affected patients</arm_group_label>
    <description>20 matched controls not suffering from bronchiolitis obliterans</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood, serum, and Sputum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The study is carried out in children and young adults (6 to 25 years). Both the patients
        (20) and the healthy subjects (20) are recruited from the outpatient clinic of the
        departement of Pediatric Allergy and Pulmonology, University Clinic, JW Goethe University,
        Frankfurt/M, Germany.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  informed consent

          -  between 6 and 25 years of age

          -  Known bronchiolitis obliterans / no bronchiolitis obliterans(depending on the study
             group)

          -  Ability to perform lung function tests and inhalation

        Exclusion Criteria:

          -  &lt;6 and &gt; 25 years of age on the day of written informed consent

          -  Acute illness with systemic or bronchial inflammation

          -  every chronic condition or infection (eg HIV, tuberculosis, malignancy)

          -  pregnancy

          -  known alcohol and/ or drug abuse

          -  Inability to understand the extent and scope of the study

          -  Participation in another study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Rosewich, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Goethe University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital, Goethe-University</name>
      <address>
        <city>Frankfurt am Main</city>
        <state>Hessen</state>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Kurland G, Michelson P. Bronchiolitis obliterans in children. Pediatr Pulmonol. 2005 Mar;39(3):193-208. Review.</citation>
    <PMID>15635614</PMID>
  </reference>
  <reference>
    <citation>Pichler M, Herrmann G, Schmidt H, Ahrens P, Zielen S. Persistent adenoviral infection and chronic obstructive bronchitis in children: is there a link? Pediatr Pulmonol. 2001 Nov;32(5):367-71.</citation>
    <PMID>11596161</PMID>
  </reference>
  <reference>
    <citation>Pichler MN, Reichenbach J, Schmidt H, Herrmann G, Zielen S. Severe adenovirus bronchiolitis in children. Acta Paediatr. 2000 Nov;89(11):1387-9.</citation>
    <PMID>11106056</PMID>
  </reference>
  <reference>
    <citation>Gerhardt SG, McDyer JF, Girgis RE, Conte JV, Yang SC, Orens JB. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study. Am J Respir Crit Care Med. 2003 Jul 1;168(1):121-5. Epub 2003 Apr 2.</citation>
    <PMID>12672648</PMID>
  </reference>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2011</study_first_submitted>
  <study_first_submitted_qc>March 31, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 1, 2011</study_first_posted>
  <last_update_submitted>June 26, 2012</last_update_submitted>
  <last_update_submitted_qc>June 26, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 27, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johann Wolfgang Goethe University Hospital</investigator_affiliation>
    <investigator_full_name>Dr. med. Martin Rosewich</investigator_full_name>
    <investigator_title>Martin Rosewich, MD</investigator_title>
  </responsible_party>
  <keyword>Bronchiolitis obliterans</keyword>
  <keyword>HRCT</keyword>
  <keyword>Sputum</keyword>
  <keyword>Blood</keyword>
  <keyword>Inflammation</keyword>
  <keyword>adaptive immune system</keyword>
  <keyword>innate immune system</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Bronchiolitis</mesh_term>
    <mesh_term>Bronchiolitis Obliterans</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

